Evidence map›Paper›PMID 27993853›Full record

ArticleAntimicrobial agents and chemotherapy2017

Jane Freeman, Sally Pilling, Jonathan Vernon, Mark H Wilcox

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Characterization of High-Linezolid-MICInfection and drug resistance · 2025
    Article
  3. The Urgent Threat ofBiomedicines · 2023
    Review
  4. Review
  5. Antimicrobial agents and chemotherapy · 2021
    Article
  6. Investigational Treatment Agents for RecurrentJournal of experimental pharmacology · 2020
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jane FreemanMicrobiology, Leeds Teaching Hospitals Trust, University of Leeds, Leeds, United Kingdom Jane.freeman4@nhs.net.
Sally PillingHealthcare Associated Infections Research Group, Leeds Institute for Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Jonathan VernonHealthcare Associated Infections Research Group, Leeds Institute for Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Mark H WilcoxMicrobiology, Leeds Teaching Hospitals Trust, University of Leeds, Leeds, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatments for

Indexed as

AminoglycosidesAnti-Bacterial AgentsClostridioides difficileDrug Resistance, Multiple, BacterialEnterocolitis, PseudomembranousFluoroquinolonesHumansLinezolidMicrobial Sensitivity TestsMoxifloxacinOxazolidinonesPolymerase Chain ReactionPyrrolidinesQuinolonesRibotypingAminoglycosidesAnti-Bacterial AgentsFluoroquinolonesLinezolidMCB3681MoxifloxacinOxazolidinonesPyrrolidinesQuinolonesantimicrobial susceptibilityClostridium difficileMCB3681

Identifiers

PMID27993853
PMCPMC5328556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.